Molecular determinants for the action of psychostimulants
精神兴奋剂作用的分子决定因素
基本信息
- 批准号:8911290
- 负责人:
- 金额:$ 12.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-15 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgonistAmphetaminesAntipsychotic AgentsArrestinsAwardBehavioralBindingBiological ModelsBiologyBiophysicsCatecholaminesCell physiologyCellsChemicalsCocaineCollaborationsComputer AnalysisCrystallographyDataDevelopmentDopamineDopamine ReceptorDrug abuseDrug effect disorderElectron Spin Resonance SpectroscopyEmotionalFacultyFamilyFluorescence SpectroscopyFosteringFunctional disorderFundingG-Protein-Coupled ReceptorsGTP-Binding ProteinsGoalsGrantGrowthHomologous GeneImageInstitutesInternetJournalsK-Series Research Career ProgramsLaboratoriesLaboratory StudyLifeManuscriptsMembrane ProteinsMental disordersMentorsMentorshipMethodsMolecularMolecular BiologyMolecular ProbesMolecular TargetMusNatureNeurosciencesNeurotransmittersNew YorkOpioid ReceptorPeer ReviewPharmacologyPhysiciansPhysiologicalPlayProcessPropertyProteinsPsychiatryPublicationsPublishingRegulationResearchResearch MethodologyRewardsRoleScienceSenior Scientist AwardSignal TransductionSpecificityStructureStructure-Activity RelationshipStudentsSubstance abuse problemSurgeonSystemTherapeuticTimeUnited States National Academy of SciencesUnited States National Institutes of HealthUniversitiesWorkbasecareercareer developmentcognitive reappraisalcollegedopamine transporterdrug of abuseflexibilityflyinhibitor/antagonistinsightmedical specialtiesmembermolecular recognitionnervous system disordernovelnovel strategiesprofessorprogramsprotein activationpsychostimulantreceptorreuptakesingle moleculestructural biologytransmission process
项目摘要
DESCRIPTION (provided by applicant): The catecholamine dopamine (DA) plays a key role in the regulation of cognitive, emotional, and behavioral functions. Abnormalities in its regulation have been implicated in drug abuse as well as several psychiatric and neurological disorders. DA exerts it actions at D2-like and D1-like receptors, members of the G protein-coupled receptor (GPCR) family. DA reuptake by the DA transporter (DAT) is a principal mechanism for terminating dopaminergic transmission, and this protein is the primary molecular target of amphetamine, cocaine, and other psychostimulants. The Javitch laboratory studies structure-function relationships and mechanisms of regulation of neurotransmitter transporters and related bacterial transporters, as well as mechanisms of dopamine receptor oligomerization and function. His long-term research goals are to: 1) Understand the structural bases of agonist and antagonist binding and specificity in G protein-coupled receptors, with a current focus on DA and opioid receptors. 2) Determine how agonist binding is transduced into G-protein activation and arrestin recruitment and signaling. 3) Determine the structural bases of substrate translocation and inhibitor binding to neurotransmitter transporters and the dynamics associated with transport using biophysical and structural approaches in parallel with computational analysis. 4) Determine the mechanistic bases of AMPH-induced DA efflux and the role of regulation of these processes in sensitization and substance abuse. The K Award enables the candidate to devote focused effort to the exploration of new approaches, novel systems and various multi-disciplinary methods and collaborations aimed at one of the central goals of the research program in the laboratory - the mechanisms of drugs of abuse. The candidate's laboratory is pursuing membrane protein crystallography and electron paramagnetic resonance & single molecule fluorescence spectroscopy of bacterial homologs of neurotransmitter transporters. This work is now being extended to single molecule imaging of receptors in living cells. The lab is also pursuing work in genetically modified flies and mice as model systems to probe molecular and mechanistic insights in a physiological background. These new approaches are being developed and used to maintain the candidate's research at the leading edge of the field of molecular mechanisms of drug abuse and actions of antipsychotic drugs. The support of the K05 Award would play an essential role in the candidate's continued growth by giving him the flexibility to focus on expanding his research methodologies and to fuse his own professional growth with that of his research program as well as extensive mentorship of his trainees and junior faculty.
描述(由申请人提供):儿茶酚胺多巴胺(DA)在认知、情感和行为功能的调节中起关键作用。在其监管方面的不当行为与药物滥用以及几种精神和神经疾病有关。DA作用于D2样和D1样受体,即G蛋白偶联受体(GPCR)家族成员。DA转运蛋白(DAT)的DA重摄取是终止多巴胺能传递的主要机制,该蛋白是苯丙胺、可卡因和其他精神兴奋剂的主要分子靶点。Javitch实验室研究神经递质转运蛋白和相关细菌转运蛋白的结构-功能关系和调节机制,以及多巴胺受体寡聚化和功能的机制。他的长期研究目标是:1)了解G蛋白偶联受体中激动剂和拮抗剂结合和特异性的结构基础,目前重点是DA和阿片受体。2)确定激动剂结合如何被转换成G蛋白激活和抑制蛋白募集和信号传导。3)确定底物易位和抑制剂结合到神经递质转运蛋白的结构基础,以及使用生物物理和结构方法与计算分析并行的与运输相关的动力学。4)确定AMPH诱导的DA外排的机制基础以及这些过程在致敏和物质滥用中的调节作用。K奖使候选人能够专注于探索新方法,新系统和各种多学科方法以及旨在实验室研究计划的中心目标之一的合作-滥用药物的机制。候选人的实验室正在进行膜蛋白晶体学和电子顺磁共振和神经递质转运蛋白的细菌同系物的单分子荧光光谱学。这项工作现在正在扩展到活细胞中受体的单分子成像。该实验室还在进行转基因苍蝇和小鼠的研究,作为在生理背景下探索分子和机制见解的模型系统。这些新的方法正在开发和使用,以保持候选人的研究在药物滥用和抗精神病药物的作用的分子机制领域的前沿。K 05奖的支持将在候选人的持续成长中发挥至关重要的作用,使他能够灵活地专注于扩大他的研究方法,并将自己的专业成长与他的研究计划以及他的学员和初级教师的广泛指导相融合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan A Javitch其他文献
Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base
- DOI:
10.1186/1471-2105-8-177 - 发表时间:
2007-05-30 - 期刊:
- 影响因子:3.300
- 作者:
Lucy Skrabanek;Marta Murcia;Michel Bouvier;Lakshmi Devi;Susan R George;Martin J Lohse;Graeme Milligan;Richard Neubig;Krzysztof Palczewski;Marc Parmentier;Jean-Philippe Pin;Gerrit Vriend;Jonathan A Javitch;Fabien Campagne;Marta Filizola - 通讯作者:
Marta Filizola
Jonathan A Javitch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan A Javitch', 18)}}的其他基金
Impact of metabotropic glutamate receptor heteromerization on signaling and pharmacology
代谢型谷氨酸受体异聚化对信号传导和药理学的影响
- 批准号:
10637938 - 财政年份:2023
- 资助金额:
$ 12.96万 - 项目类别:
Functional validation of a role for the candidate gene Ctr9 in psychostimulant action
候选基因 Ctr9 在精神兴奋作用中的作用的功能验证
- 批准号:
10392183 - 财政年份:2022
- 资助金额:
$ 12.96万 - 项目类别:
Development of dopamine D2 receptor-targeted DARTs
多巴胺 D2 受体靶向 DART 的开发
- 批准号:
10376835 - 财政年份:2021
- 资助金额:
$ 12.96万 - 项目类别:
Probing mechanisms of amphetamine action at plasma membrane and vesicular transporters in vitro and in vivo
体外和体内苯丙胺对质膜和囊泡转运蛋白作用的探讨机制
- 批准号:
9449417 - 财政年份:2017
- 资助金额:
$ 12.96万 - 项目类别:
Probing mechanisms of amphetamine action at plasma membrane and vesicular transporters in vitro and in vivo
体外和体内苯丙胺对质膜和囊泡转运蛋白作用的探讨机制
- 批准号:
9311046 - 财政年份:2017
- 资助金额:
$ 12.96万 - 项目类别:
Modulation of dopaminergic neurotransmission by ADGRL3, an adhesion GPCR associated with ADHD susceptibility
ADGRL3(一种与 ADHD 易感性相关的粘附 GPCR)对多巴胺能神经传递的调节
- 批准号:
9350414 - 财政年份:2016
- 资助金额:
$ 12.96万 - 项目类别:
Modulation of dopaminergic neurotransmission by ADGRL3, an adhesion GPCR associated with ADHD susceptibility
ADGRL3(一种与 ADHD 易感性相关的粘附 GPCR)对多巴胺能神经传递的调节
- 批准号:
9227923 - 财政年份:2016
- 资助金额:
$ 12.96万 - 项目类别:
Delineating the genetic basis of amphetamine sensitivity using a Drosophila behavioral model
使用果蝇行为模型描述安非他明敏感性的遗传基础
- 批准号:
9920454 - 财政年份:2016
- 资助金额:
$ 12.96万 - 项目类别:
Delineating the genetic basis of amphetamine sensitivity using a Drosophila behavioral model
使用果蝇行为模型描述安非他明敏感性的遗传基础
- 批准号:
9920689 - 财政年份:2016
- 资助金额:
$ 12.96万 - 项目类别:
Delineating the genetic basis of amphetamine sensitivity using a Drosophila behavioral model
使用果蝇行为模型描述安非他明敏感性的遗传基础
- 批准号:
10160626 - 财政年份:2016
- 资助金额:
$ 12.96万 - 项目类别:
相似海外基金
Relationship between neurotoxicity and the chemical structures of amphetamines
安非他明的神经毒性与化学结构的关系
- 批准号:
25860103 - 财政年份:2013
- 资助金额:
$ 12.96万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Search for protein expression in amphetamines treated mouse heart : Challenge to the diagnosis for the sudden death of amphetamines abusers
寻找安非他明治疗小鼠心脏中的蛋白质表达:对安非他明滥用者猝死诊断的挑战
- 批准号:
22659138 - 财政年份:2010
- 资助金额:
$ 12.96万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
- 批准号:
8312648 - 财政年份:2010
- 资助金额:
$ 12.96万 - 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
- 批准号:
8531900 - 财政年份:2010
- 资助金额:
$ 12.96万 - 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
- 批准号:
8715749 - 财政年份:2010
- 资助金额:
$ 12.96万 - 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
- 批准号:
8144930 - 财政年份:2010
- 资助金额:
$ 12.96万 - 项目类别:
Translational Genetics and Dopamine Signaling in Sensitivity to Amphetamines
安非他明敏感性中的转化遗传学和多巴胺信号传导
- 批准号:
7675601 - 财政年份:2009
- 资助金额:
$ 12.96万 - 项目类别:
Simultaneous determination of ephedrines, amphetamines, cocaine, cocaine metabolites, and opiates and interaction in the rat
大鼠体内麻黄碱、安非他明、可卡因、可卡因代谢物和阿片类药物的同时测定及其相互作用
- 批准号:
17590585 - 财政年份:2005
- 资助金额:
$ 12.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study for practical use of two chiral analyses of amphetamines by gas chromatography-mass spectrometry
气相色谱-质谱法对苯丙胺两种手性分析的实用化研究
- 批准号:
17590588 - 财政年份:2005
- 资助金额:
$ 12.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clinical Pharmacology of 3,4-Methylenedioxy Amphetamines
3,4-亚甲二氧基安非他明的临床药理学
- 批准号:
6870119 - 财政年份:2004
- 资助金额:
$ 12.96万 - 项目类别: